- Home
- EQNR vs CAH Comparison
EQNR vs CAH Comparison
Compare EQNR & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EQNR | CAH |
|---|---|---|
| Founded | 1972 | 1979 |
| Country | Norway | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.2B | 50.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EQNR | CAH |
|---|---|---|
| Price | $24.70 | $206.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 12 |
| Target Price | $28.20 | ★ $206.08 |
| AVG Volume (30 Days) | ★ 4.7M | 1.4M |
| Earning Date | 02-04-2026 | 02-05-2026 |
| Dividend Yield | ★ 5.83% | 0.98% |
| EPS Growth | N/A | ★ 27.25 |
| EPS | 2.15 | ★ 6.63 |
| Revenue | $107,066,000,000.00 | ★ $234,310,000,000.00 |
| Revenue This Year | $2.49 | $16.58 |
| Revenue Next Year | N/A | $8.15 |
| P/E Ratio | ★ $11.96 | $31.46 |
| Revenue Growth | 2.15 | ★ 4.39 |
| 52 Week Low | $21.41 | $120.72 |
| 52 Week High | $28.27 | $215.48 |
Technical Indicators
Market Signals| Indicator | EQNR | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 51.69 |
| Support Level | $24.84 | $199.95 |
| Resistance Level | $25.74 | $215.48 |
| Average True Range (ATR) | 0.57 | 4.46 |
| MACD | 0.14 | -0.12 |
| Stochastic Oscillator | 63.08 | 43.71 |
Price Performance
Historical ComparisonAbout EQNR Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2024 (52% liquids) and ended 2024 with 6.1 billion barrels of proven reserves (42% liquids). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.